Skip to main content
Hempsana Holdings logo

Hempsana Holdings — Investor Relations & Filings

Ticker · HMPS ISIN · CA4238651042 CSE Manufacturing
Open in API
Filings indexed 155 across all filing types
Latest filing 2023-06-23 Interim / Quarterly Rep…
Country CA Canada
Listing CSE HMPS

About Hempsana Holdings

https://www.hempsana.ca

Hempsana Holdings Ltd. is a specialized manufacturer focused on cannabis derivatives extraction and purification. The company's core activities involve the production of high-quality cannabinoid oils and extracts, encompassing both major and minor cannabinoids. Hempsana specializes in processing Active Pharmaceutical Ingredient (API) grade CBD, positioning itself as a provider of high-quality inputs for medicinal and consumer applications. The company also manufactures cannabis-infused end-products, utilizing its extracts, such as full spectrum resin and distillate, often through custom manufacturing agreements for finished goods.

Recent filings

Filing Released Lang Actions
Interim MD&A - English.pdf
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Management Discussion and Analysis for the three months ended March 31, 2023' and contains detailed financial data, operational results, liquidity and capital resources discussion, and forward-looking statements. It references the interim condensed consolidated financial statements for the three months ended March 31, 2023, indicating it is a quarterly report. The length is substantial (15,000 characters), and it contains substantive financial data and analysis, not just an announcement or certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR). Q1 2023
2023-06-23 English
Interim financial statements/report – English.pdf
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Interim Condensed Consolidated Financial Statements' for the three months ended March 31, 2023, and is unaudited. It contains detailed financial statements including the statement of financial position, statement of loss and comprehensive loss, statement of changes in shareholders' equity, and statement of cash flows. The notes to the financial statements discuss the nature of operations, basis of presentation, revenue recognition, and other accounting policies. The document is prepared in accordance with IAS 34, which governs interim financial reporting. The length of the document (15,000 characters) and the presence of substantive financial data and analysis confirm it is a full interim financial report rather than a brief announcement or certification. Therefore, this document fits the definition of an Interim / Quarterly Report (IR). Q1 2023
2023-06-23 English
News release - English.pdf
Regulatory Filings
2023-06-16 English
52-109FV1 - Certification of annual filings - CFO (E).pdf
Regulatory Filings
2023-06-16 English
Annual MD&A - English.pdf
Regulatory Filings
2023-06-16 English
AB form 13-501F1 (class 1 and 3B reporting issuers - participation fee).pdf
Regulatory Filings
2023-06-16 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.